Skip to content
10-K

Annual Report

GREEN VISION BIOTECHNOLOGY CORP.

0001640334-21-000040

← back to feed
Filed
Jan 7, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Jan 1, 2021 16.08M sh
Capex FY 2019 · Dec 31, 2019 $0
Capex restated FY 2019 · Dec 31, 2018 $613
Eps Diluted FY 2019 · Dec 31, 2019 −$0.31
Eps Diluted FY 2019 · Dec 31, 2018 −$0.85
Eps Basic FY 2019 · Dec 31, 2019 −$0.31
Eps Basic FY 2019 · Dec 31, 2018 −$0.85
Shares Diluted FY 2019 · Dec 31, 2018 160.79M sh
Operating Cash Flow FY 2019 · Dec 31, 2018 −$314.57K
Current Liabilities FY 2019 · Dec 31, 2018 $9.63M
Total Liabilities FY 2019 · Dec 31, 2018 $9.63M
Current Assets FY 2019 · Dec 31, 2018 $36.65K
Total Assets FY 2019 · Dec 31, 2018 $3.23M
Net Income FY 2019 · Dec 31, 2018 −$1.36M
Operating Income FY 2019 · Dec 31, 2018 −$1.06M
Gross Profit FY 2019 · Dec 31, 2018 $21.41K
Revenue FY 2019 · Dec 31, 2018 $99.6K
Cash And Equivalents FY 2019 · Dec 31, 2017 $38.93K
Stockholders Equity FY 2019 · Dec 31, 2017 −$5.09M